FreshLeaf Analytics News

FreshLeaf’s top ten 2020 trends for Australia’s medical cannabis industry You don’t need a crystal ball to know that 2020 is going to be a big year for cannabis in Australia and around the world. But what does that mean exactly for companies, patients and regulators? Here are the top 10 most important trends in...Read More

New Zealand finalises medical cannabis regulations Today the Misuse of Drugs (Medicinal Cannabis) Regulations 2019 were published, setting out the regulations for a New Zealand cannabis industry and making significant changes to patient access. Here are the major features of New Zealand’s new scheme: Improved patient access Firstly, NZ doctors have been prescribing a variety...Read More

New Zealand draft recreational cannabis legislation released Whether you like it or not, having both medical and non-medical cannabis frameworks in place means there will be interaction between the two. Despite the qualitative differences between medical and non-medical products, services, regulations and patients/consumers, the legalisation of non-medical cannabis impacts medical users.  FreshLeaf Analytics and the...Read More

As medical cannabis access gets easier, governments will miss out on public health data Recent reforms at the State level in NSW and QLD mean increasing patient numbers will be traded off against quality data collection. This is good for patients but will make it harder for governments and industry to track market expansion. A...Read More

ANTG second Australian company to bring domestically cultivated products to market   ANTG, a NSW-based medicinal cannabis company, has announced that their first product is ready for Australian patients.  The news, published on the company’s website, highlighted the registration of the product as an export-only medicine, listed on the Australian Register of Therapeutic Goods (ARTG)....Read More

Australia launches Senate inquiry into medical cannabis patient access The Australian Senate has just launched an inquiry into patient access to medical cannabis. The matter was referred by the leader of the Greens, Senator Di Natale, to the Community Affairs References Committee. The Committee is now required to report on the matter before February 12th,...Read More

ODC consults with industry on upcoming changes to licenses and more   The ODC has a lot on it’s plate right now – re-configuring their operational structure, dealing with the influx of new applicants, managing existing license holders, and planning for the implementation of the 26 recommendations that came out of the McMillan review. This...Read More

Patient access to medical cannabis in Western Australia set to improve   We wrote recently about how empowering GP prescribers in QLD is partly responsible for the disproportionate levels of SAS-B approvals in that State. And how NSW would be the next to follow suit, having made similar changes to their State approval system.   ...Read More

Patient access to medical cannabis October figures released by Rhys Cohen 1. Record growth continues Another record month for medicinal cannabis approvals in Australia via the Special Access Scheme Category B route! 3,594 approvals were issued in October 2019. It’s worth remembering how far the Australian market has come in just the last 12 months....Read More